Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Evaluation of the efficacy of Conbercept in the treatment of diabetic macular edema based on OCTA

Trial Profile

Evaluation of the efficacy of Conbercept in the treatment of diabetic macular edema based on OCTA

Status: Recruiting
Phase of Trial: Phase II

Latest Information Update: 29 Sep 2020

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Conbercept (Primary)
  • Indications Diabetic macular oedema
  • Focus Therapeutic Use
  • Most Recent Events

    • 28 Aug 2020 Planned number of patients changed from 100 to 120, according to trial deisgn published in the Medicine
    • 28 Aug 2020 Trial design published in the Medicine
    • 28 Aug 2020 According to trial design published in the Medicine, Progress of the trial (Till date: 6 July 2020), recruitment has started at all participating sites(n=7) and a total of 28 eyes have been recruited into the trial till date.
Subscriber content

You need to be a logged in subscriber to view this content.

If your organization has a subscription then there are several options available to help you access AdisInsight, even while working remotely.

  • IP authentication when working within your organization’s network.
  • with username/password or try via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days.
  • Contact us at AsktheExpert.AdisInsight@springer.com for assistance.

If your organization does not have a subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Buy a PDF version of the profile.
  • Request a free trial
Back to top